(MedPage Today) — Patients undergoing matched-donor stem cell transplants lived four times longer without episodes of graft-versus-host disease (GVHD) with post-transplant cyclophosphamide-cyclosporin prophylaxis, a randomized trial showed.
Median…
Source link : https://www.medpagetoday.com/meetingcoverage/eha/116064
Author :
Publish date : 2025-06-13 16:24:00
Copyright for syndicated content belongs to the linked Source.
